(Q36760100)

16 August 2017

1 reference

title

Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature (English)

1 reference

chronic obstructive pulmonary disease

16 August 2017

main subject

1 reference

Talia S Foster

1

1 reference

16 August 2017

Jeffrey D Miller

2

1 reference

16 August 2017

Jeno P Marton

3

1 reference

16 August 2017

John P Caloyeras

4

1 reference

16 August 2017

Mason W Russell

5

1 reference

16 August 2017

Joseph Menzin

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

16 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

211-218

1 reference

Predicting the costs of managing patients with chronic obstructive pulmonary disease

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

The burden of COPD in the U.S.A.: results from the Confronting COPD survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Pharmacoeconomic evaluation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Epidemiology and costs of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Costs of occupational COPD and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Direct medical cost of chronic obstructive pulmonary disease in the U.S.A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

The economic burden of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

The economic impact of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Lost income and work limitations in persons with chronic respiratory disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

The workplace impact of acute exacerbations of chronic bronchitis (AECB); A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

Contemporary management of chronic obstructive pulmonary disease: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550601009396

10.1080/15412550601009396

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference